Biopharmaceutical compositions comprising interleukin-5 antibody
US10870695B2 · kind B2 · utility
7Cited by
16References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 22, 2016 |
| Grant date | Dec 22, 2020 |
| Priority date | — |
| Expiry date | Aug 22, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/94
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to compositions, for treating interleukin 5 (IL-5) mediated diseases, and related methods.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.